NEW YORK (AP) — Bristol-Myers Squibb to buy Celgene in a cash and stock deal worth $74 billion.
FEATURING:
VantagE
Point A.I.
Hot Stocks Outlook
TraderPlanet’s Quick Guide to Candlesticks – By Darrell Jobman
NEW YORK (AP) — Bristol-Myers Squibb to buy Celgene in a cash and stock deal worth $74 billion.
NEW YORK (AP) — Forget vending machines, PepsiCo is testing a way to bring snacks directly to college students. The chip and beverage maker says it...
BERLIN (AP) — Authorities in Germany and the Netherlands are searching for up to 270 shipping containers lost at sea by a cargo ship caught in a...
FUTURES
EDUCATION